Hypoxia-inducible factor-1α is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer

Histopathology

Volumn 46, Issue 1, 2005, Pages 31-36

  Bos, R ^a   Van Diest, Paul J ^b   De Jong, J S ^c   Van Der Groep, P ^b   Van Der Valk, P ^a   Van Der Wall, E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Breast cancer; Growth factors; HIF 1; Hypoxia

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED GROWTH FACTOR BB; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR BINDING; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION;

AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; EPITHELIAL CELLS; EUKARYOTIC INITIATION FACTOR-3; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPH NODES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STROMAL CELLS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 13244284943     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02045.x     Document Type: Article

References (52)

1. Folkman J, Mener E, Abernathy C et al. Isolation of a tumor factor responsible or angiogenesis. J. Exp. Med. 1971; 133; 275-288.
2. Folkman J, Watson K, Ingber D et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339; 58-61.
3. de Jong JS, van Diest PJ, van der Valk P, Baak JP. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis. J. Pathol. 1998; 184; 53-57.
4. Carmeliet P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol 1999; 237; 133-158.
5. Eriksson U, Alitalo K. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top. Microbiol. Immunol. 1999; 237; 41-57.
6. Dachs GU, Patterson AV, Firth JD et al. Targeting gene expression to hypoxic tumor cells. Nat. Med. 1997; 3; 515-520.
7. Gasparini G, Toi M, Gion M et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl Cancer Inst. 1997; 89; 139-147.
8. Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13; 9-22.
9. Neufeld G, Cohen T, Shraga N et al. The neuropilins; multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 2002; 12; 13-19.
10. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92; 735-745.
11. Westermark B. Claesson-Welsh L, Heldin CH. Structural and functional aspects of the receptors for platelet-derived growth factor. Prog. Growth Factor Res. 1989; 1; 253-266.
12. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407; 249-257.
13. Mignatti P, Tsuboi R, Robbins E et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 1989; 108; 671-682.
14. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 1988; 948; 67-85.
15. Moscatelli D, Presta M, Rifkin DB. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis, and migration. Proc. Natl. Acad. Sci. USA 1986; 83; 2091-2095.
16. Humphreys RC, Hennighausen L. Transforming growth factor alpha and mouse models of human breast cancer. Oncogens 2000; 19; 1085-1091.
17. Giaccone G. Clinical impact of novel treatment strategies. Oncogene 2002; 21; 6970-6981.
18. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol 1992; 12; 5447-5454.
19. 2 tension. Proc. Natl Acad. Sci. USA 1995; 92; 5510-5514.
20. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000; 14; 1983-1991.
21. 2 sensing. Science 2001; 292; 464-468.
22. 2-regulated prolyl hydroxylation. Science 2001; 292; 468-472.
23. Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 2000; 35; 71-103.
24. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 1996; 16; 4604-4613.
25. Caniggia I, Mostachfi H, Winter J et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J. Clin. Invest. 2000; 105; 577-587.
26. Feldser D, Agani F, Iyer NV et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 1999; 59; 3915-3918.
27. Gerber HP, Condorelli F, Park J et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 1997; 272; 23659-23667.
28. Bos R, Zhong H, Hanrahan CF et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl Cancer Inst. 2001; 93; 309-314.
29. Bos R, van der Groep P, Greijer AE et al. Levels of hypoxia-inducible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97; 1573-1581.
30. Elston CW, Ellis 10. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
31. van Diest PJ. No consent should be needed for using leftover body material for scientific purposes. BMJ 2002; 325; 648-651.
32. de Jong JS, van Diest PJ, van der Valk P et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops. J. Pathol. 1998; 184; 44-52.
33. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999; 59; 5830-5835.
34. de Jong JS, van Diest PJ, Baak JP. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab. Invest. 1995; 73; 922-926.
35. Weidner N, Semple JP, Welch WR et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl J. Med. 1991; 324; 1-8.
36. Weidner N, Folkman J, Pozza F et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl Cancer Inst. 1992; 84; 1875-1887.
37. Birner P, Gatterbauer B, Oberhuber G et al. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001; 92; 165-171.
38. Stvridis E, Giatromanolaki A, Gatter KC et al. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002; 95; 1055-1063.
39. Takahashi R., Tanaka S, Hiyama T et al. Hypoxia-inducible factor-1 alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol. Report 2003; 10; 797-802.
40. Kuwai T, Kitadai Y, Tanaka S et al. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int. J. Cancer 2003; 105; 176-181.
41. de Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000; 36; 306-312.
42. Mabjeesh NJ, Escuin D, LaVallee TM et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003; 3; 363-375.
43. Semenza GL. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003: 3; 721-732.
44. Fang J, Yan L, Shing Y et al. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic Sbroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Cancer Res. 2001; 61; 5731-5735.
45. Laughner E, Taghavi P, Chiles K et al. Her2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (hif-1alpha) synthesis: novel mechanism for hif-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 2001; 21; 3995-4004.
46. Zhong H, Chiles K, Feldser D et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000; 60; 1541-1545.
47. Gunaratnam L, Morley M, Franovic A et al. Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J. Biol. Chem. 2003; 278; 44966-44974.
48. Kourembanas S, Hannan RL, Faller DV. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J. Clin. Invest. 1990; 86; 670-674.
49. Ulleras E, Wilcock A, Miller SJ et al. The sequential activation and repression of the human PDGF-B gene during chronic hypoxia reveals antagonistic roles for the depletion of oxygen and glucose. Growth Factors 2001; 19; 233-245.
50. Zhang SX, Gozal D, Sachleben LR Jr et al. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells. FASEB J. 2003; 17; 1709-1711.
51. Giatromanolaki A, Koukourakis MI, Sivridis E et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer 2001; 85; 881-890.
52. Li J, Shworak NW, Simons M. Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. J. Cell Sci. 2002; 115; 1951-1959.